In the process of conquering difficult drug targets, we cooperate with research institutions, biotechnology companies, and pharmaceutical companies around the world at all stages of drug discovery, clinical research, and commercialization. We look for the best therapies and bring products to the global market through external licensing, product introduction, and co-development.
Global commercialization and development collaboration
We have signed a global, strategic collaboration agreement to develop and commercialise SHP2 inhibitors with AbbVie on June 1, 2020.
Click here to know more about our partnership.
Using the latest research to bring hope to patients
Click here to know more about our partnership.